New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Managing medication for loved ones

Managing medication for loved ones

by Mayo Clinic News NetworkCredit: CC0 Public DomainSome older people struggle with remembering to take their medications or organizing them effectively. Adult children, like yourself, can help by tak
Breakthroughs January 26,2024
Managing medication for loved ones

Managing medication for loved ones

by Mayo Clinic News NetworkCredit: CC0 Public DomainSome older people struggle with remembering to take their medications or organizing them effectively. Adult children, like yourself, can help by tak
Breakthroughs January 26,2024
Study reports progress in long-term protection against ovarian cancer tumors

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or
Oncology January 26,2024
Study reports progress in long-term protection against ovarian cancer tumors

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or
Oncology January 26,2024
New study reveals how blood cancer cells escape the immune system's natural killer cells

New study reveals how blood cancer cells escape the immune system's natural killer cells

byUniversity of HelsinkiGraphical abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.11.008The advent of T-cell therapies, where cells of the immune system are directed towa
Oncology January 26,2024
New study reveals how blood cancer cells escape the immune system's natural killer cells

New study reveals how blood cancer cells escape the immune system's natural killer cells

byUniversity of HelsinkiGraphical abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.11.008The advent of T-cell therapies, where cells of the immune system are directed towa
Oncology January 26,2024
First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with
Oncology January 26,2024
First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with
Oncology January 26,2024
Novel pancreatic cancer organoids show promise for effective screening of anticancer drugs

Novel pancreatic cancer organoids show promise for effective screening of anticancer drugs

byUniversity of TokyoGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113420Pancreatic ductal adenocarcinoma (PDAC), that arises from pancreatic epithelial c
Breakthroughs January 26,2024
Novel pancreatic cancer organoids show promise for effective screening of anticancer drugs

Novel pancreatic cancer organoids show promise for effective screening of anticancer drugs

byUniversity of TokyoGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113420Pancreatic ductal adenocarcinoma (PDAC), that arises from pancreatic epithelial c
Breakthroughs January 26,2024
Study: Solid organ transplant patients benefit from COVID-19 treatment

Study: Solid organ transplant patients benefit from COVID-19 treatment

byCedars-Sinai Medical CenterTix-Cil dosing and infections during the study period. The frequency and timing of Tix-Cil dosing and SARS-CoV-2 infections occurring in the study cohort is shown in
Breakthroughs January 26,2024
Study: Solid organ transplant patients benefit from COVID-19 treatment

Study: Solid organ transplant patients benefit from COVID-19 treatment

byCedars-Sinai Medical CenterTix-Cil dosing and infections during the study period. The frequency and timing of Tix-Cil dosing and SARS-CoV-2 infections occurring in the study cohort is shown in
Breakthroughs January 26,2024
The paradoxical role of white blood cells in the spread of breast cancer

The paradoxical role of white blood cells in the spread of breast cancer

byKarolinska InstitutetCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113507A new study from Karolinska Institutet,publishedinCell Reports, shows that tumor-
Oncology January 26,2024
The paradoxical role of white blood cells in the spread of breast cancer

The paradoxical role of white blood cells in the spread of breast cancer

byKarolinska InstitutetCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113507A new study from Karolinska Institutet,publishedinCell Reports, shows that tumor-
Oncology January 26,2024
New study highlights COVID-19's adaptive strategy for infection

New study highlights COVID-19's adaptive strategy for infection

byUniversity of Minnesota Medical SchoolCryo-EM analyses of residue 417 in regulating the conformation of recombinant SARS-CoV-2 spike ectodomain. Prototypic SARS-CoV-2 spike ectodomains contain
Public Health & Prevention January 26,2024
New study highlights COVID-19's adaptive strategy for infection

New study highlights COVID-19's adaptive strategy for infection

byUniversity of Minnesota Medical SchoolCryo-EM analyses of residue 417 in regulating the conformation of recombinant SARS-CoV-2 spike ectodomain. Prototypic SARS-CoV-2 spike ectodomains contain
Public Health & Prevention January 26,2024
Treating tuberculosis when antibiotics no longer work

Treating tuberculosis when antibiotics no longer work

byUniversity of CologneCredit:Cell Chemical Biology(2024). DOI: 10.1016/j.chembiol.2023.12.007Researchers have identified new antibiotic molecules that target Mycobacterium tuberculo
Breakthroughs January 26,2024
Treating tuberculosis when antibiotics no longer work

Treating tuberculosis when antibiotics no longer work

byUniversity of CologneCredit:Cell Chemical Biology(2024). DOI: 10.1016/j.chembiol.2023.12.007Researchers have identified new antibiotic molecules that target Mycobacterium tuberculo
Breakthroughs January 26,2024
Review highlights the challenges and recent advances in targeted therapies for lupus nephritis

Review highlights the challenges and recent advances in targeted therapies for lupus nephritis

by Cactus CommunicationsSLE involves abnormal activation of both innate and adaptive immune responses, leading to systemic immune dysregulation and renal impairment. The complement system's dysfun
Immunology & Rheumatology January 26,2024
Review highlights the challenges and recent advances in targeted therapies for lupus nephritis

Review highlights the challenges and recent advances in targeted therapies for lupus nephritis

by Cactus CommunicationsSLE involves abnormal activation of both innate and adaptive immune responses, leading to systemic immune dysregulation and renal impairment. The complement system's dysfun
Immunology & Rheumatology January 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com